Science

Jun 22, 2025, 20:54

Myeloma Paper of the Day, June 22nd, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Polyclonal plasma cell (PolyPC) signature may be a key indicator for predicting progression of MGUS to myeloma; sensitivity and specificity were 70% (28/40) and 81.7% (273/334).”

Title: Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma

Authors: Fumou Sun, Yan Cheng, Catherine Ma, Hongwei Xu, Clyde Bailey, David Mery, Timothy Cody Ashby, Daisy Alapat, Yong Li, Ken H Young, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan.

You can read the Full Article in Cancer Biomarkers.

More posts featuring Robert Orlowski.

cancer Catherine Ma Clyde Bailey David Mery Fenghuang Zhan Frits Van Rhee Fumou Sun Guido Tricot Hongwei Xu John D Shaughnessy Jr. Maurizio Zangari Myeloma Myeloma Paper of the Day OncoDaily Oncology Polyclonal plasma cell PolyPC Robert Orlowski Yan Cheng

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself